The Effect of the FDA VVarning on the Use of Droperidol by U.S. Emergency Physicians

مرکز و کتابخانه مطالعات اسلامی به زبان های اروپایی

منو

" The Effect of the FDA VVarning on the Use of Droperidol by U.S. Emergency Physicians "
Richards, John R; Weiss, Steven J; Bretz, Stephen W; Schneir, Aaron B; Rinetti, Dauna; Derlet, Robert W

Document Type	:	AL
Record Number	:	931752
Doc. No	:	LA0vh5m5rf
Language of Document	:	English
Main Entry	:	Richards, John R; Weiss, Steven J; Bretz, Stephen W; Schneir, Aaron B; Rinetti, Dauna; Derlet, Robert W
Title & Author	:	The Effect of the FDA VVarning on the Use of Droperidol by U.S. Emergency Physicians [Article]\ Richards, John R; Weiss, Steven J; Bretz, Stephen W; Schneir, Aaron B; Rinetti, Dauna; Derlet, Robert W
Title of Periodical	:	Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health
Volume/ Issue Number	:	4/1
Date	:	2003
Abstract	:	Objectives: To determine if emergency physicians' (EP) use droperidol has changed since the United States Food and Drug Administration (FDA) warning of December 2001 concerning QT interval prolongation, torsade de pointes, and sudden death; and to query EP opinions regarding droperidol before and after the FDA warning and regarding potential alternative drugs.